Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment
Sponsor: Hoffmann-La Roche
Summary
This study aims to evaluate the performance of biomarkers and their responsiveness to standard-of-care treatments (Vevye® or Xiidra®), in participants with dry eye disease (DED) compared to healthy volunteers (control participants).
Official title: A Longitudinal, Open-label, Multi-center Study to Explore the Relationship Between Signs, Symptoms, Molecular and Imaging Biomarkers in Participants With Dry Eye Disease Following Anti-inflammatory Treatment
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
350
Start Date
2025-07-09
Completion Date
2026-04-30
Last Updated
2025-11-04
Healthy Volunteers
Yes
Conditions
Interventions
Vevye®
Participants will receive Vevye® (0.1% cyclosporine ophthalmic solution) as per the schedule described in the treatment arm.
Xiidra®
Participants will receive Xiidra® (5% lifitegrast ophthalmic solution) as per the schedule described in the treatment arm.
Locations (5)
Butchertown Clinical Trials
Louisville, Kentucky, United States
Andover Eye Associates
Andover, Massachusetts, United States
Oculus Research
Garner, North Carolina, United States
Total Eyecare, P.A.
Memphis, Tennessee, United States
Piedmont Eye Center
Lynchburg, Virginia, United States